Attend PACK EXPO – this year’s can’t-miss event in Chicago, Oct 23-26.
Discover solutions from 2,000+ exhibitors to advance your operations and network with colleagues at PACK EXPO International.
REGISTER TODAY

Alphabet’s ECG Watch Gets FDA Clearance

Verily’s prescription-only smart watch just received clearance from the FDA amidst the government shutdown.

Study Watch / Image: Verily
Study Watch / Image: Verily

A recent article from The Verge just reported that Verily, Alphabet’s health division, received FDA 510(k) clearance for the on-demand ECG feature on its Study smart watch. The device was announced back in April of 2017 as a test platform to determine the best method for gathering health data on a wearable device. It should be noted that the watch received FDA “clearance” as a Class II device, which is different from FDA “approval,” which is typically reserved for Class III devices.

The Study Watch uses a “single-lead” method for measuring ECGs, which are less accurate than the version you’d receive in a medical office. Verily says the Study Watch is “intended to record, store, transfer, and display single-channel ECG rhythms, and is indicated for use by healthcare professionals, adult patients with known or suspected heart conditions, and health conscious individuals.”

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub